Top 10 Promising Stocks To Watch For 2014

Being a StreetAuthority subscriber has privileges. That includes learning firsthand about our biggest breakthroughs.

I want to let you know about one such discovery. It's likely to be one of the most groundbreaking finds in our company's history and could completely change the way you invest.

We're still finalizing the research, but the results are promising. It's a new method that has produced average annual gains of 21.4% during the past decade, compared with the S&P's 7.1% a year.

 

I'll tell you more in just a moment, but first I want to reintroduce you to the man behind this research -- Michael J. Carr.

You may have heard from Mike recently in this article.

Mike is one of our brightest experts here at StreetAuthority. He also has one of the most interesting backgrounds of any analyst on our staff.

Top 10 Services Stocks To Own Right Now: CRB Futures Index(CR)

Crane Co. manufactures and sells engineered industrial products in the United States and internationally. The company operates in five segments: Aerospace & Electronics, Engineered Materials, Merchandising Systems, Fluid Handling, and Controls. The Aerospace & Electronics segment offers pressure, fuel flow, and position sensors and subsystems; brake control systems; coolant, lube and fuel pumps; and seat actuation products. This segment also provides power supplies and custom microelectronics for aerospace, defense, medical, and other applications; and electrical power components, power management products, electronic radio frequency, and microwave frequency components and subsystems for the defense, space, and military communications markets. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels for the truck trailer and recreational vehicle markets, industrial markets, and the commercial construction industry. The Merchandising Systems segmen t offers vending solutions, such as food, snack, and beverage vending machines; and vending machine software and online solutions, as well as payment solutions, including coin accepters and dispensers, coin hoppers, coin recyclers, bill validators, and bill recyclers. The Fluid Handling segment manufactures and sells various industrial and commercial valves and actuators; provides valve testing, parts, and services; manufactures and sells pumps and water purification solutions; distributes pipe, pipe fittings, couplings, and connectors; and designs, manufactures, and sells corrosion-resistant plastic-lined pipes and fittings. The Controls segment produces ride-leveling, air-suspension control valves for heavy trucks and trailers; pressure, temperature, and level sensors; ultra-rugged computers, measurement and control systems, and intelligent data acquisition products; and water treatment equipment. Crane Co. was founded in 1855 and is based in Stamford, Connecticut.

Advisors' Opinion:

• [By Chuck Carnevale]

  Next, I run graphs on liquidity ratios and additional data on various valuation ratios to include price to book value (pb), price to cash flow (pcfl), price to free cash flow (pfcfl) and others that can be seen as options on the navigation bar to the left of the sample graph which only plots the current ratio (cr), a quick ratio (qr) and for those diehards concerned with volatility [size=11.0pt;line-height:115%; font-family:"Calibri","sans-serif";mso-ascii-theme-font:minor-latin;mso-fareast-font-family: Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA">��/p>

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Crane (NYSE: CR  ) , whose recent revenue and earnings are plotted below.

• [By Seth Jayson]

  Basic guidelines
  In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Crane (NYSE: CR  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Crane doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue increased 0.6%, and inventory decreased 2.4%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue dropped 2.8%, and inventory contracted 2.4%. Over the sequential quarterly period, the trend looks OK but not great. Revenue dropped 0.4%, and inventory grew 2.0%.

Top 10 Promising Stocks To Watch For 2014: Argos Therapeutics Inc (ARGS)

Argos Therapeutics, Inc (Argos), incorporated on May 8, 1997, is a development stage biopharmaceutical company. The Company is focused on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. The Company�� advanced product candidate is AGS-003 for the treatment of metastatic renal cell carcinoma, (mRCC). As of December 31, 2010, the Company was developing a second Arcelis-based product candidate, AGS-004 for the treatment of human immunodeficiency virus (HIV), and two other product candidates: AGS-009, a monoclonal antibody for the treatment of lupus, and AGS-010, a preclinical biologic compound for the treatment of psoriasis and for organ transplantation.

The Company uses its Arcelis platform to generate Ribonucleic Acid (RNA) loaded dendritic cell immunotherapies using biological components derived from the individual patient to be treated. It manufactures these personalized therapies using that patient�� disease sample, either tumor cells in the case of cancer or a blood sample containing virus in the case of infectious disease, and dendritic cells derived from the patient�� white blood cells. The Company�� AGS-003 is tested in clinical trials in combination with sunitinib and as a monotherapy for the treatment of mRCC.

Advisors' Opinion:

• [By John Udovich]

  Last week had been a busy week for biotech IPOs and follow-on offerings plus news from small cap biotech stocks like Omeros Corporation (NASDAQ: OMER), Argos Therapeutics Inc (NASDAQ: ARGS), Revance Therapeutics Inc (NASDAQ: RVNC) and TNI BioTech (OTCMKTS: TNIB) that�� worth noting as a new trading week begins:�

• [By gurujx]

  Argos Therapeutics Inc (ARGS) Reached the 3-year Low of $6.52

  The prices of Argos Therapeutics Inc (ARGS) shares have declined to close to the 3-year low of $6.52, which is 54.8% off the 3-year high of $13.74.

Top 10 Promising Stocks To Watch For 2014: Johnson Controls Inc.(JCI)

Johnson Controls, Inc. engages in building efficiency, automotive experience, and power solutions businesses worldwide. Its building efficiency business designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, as well as building management systems, controls, and security and mechanical equipment. This business also provides technical services, energy management consulting, and operations of real estate portfolios for the non-residential buildings market. In addition, this business offers residential air conditioning and heating systems, and industrial refrigeration products. The company?s automotive experience business designs and manufactures interior products and systems for passenger cars and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. It offers seating systems and components; cockpit systems comprising instrument panels and clusters, information displays, and body controllers; overh ead systems, such as headliners and electronic convenience features; floor consoles; and door systems. This business also produces automotive interior systems for original equipment manufacturers. Its power solutions business produces lead-acid automotive batteries serving automotive original equipment manufacturers and the general vehicle battery aftermarket. This business produces lead-acid batteries, as well as offers absorbent glass mat and lithium-ion battery technologies to power hybrid vehicles. The company was formerly known as Johnson Electric Service Company and changed its name to Johnson Controls, Inc. in 1974. Johnson Controls, Inc. was founded in 1885 and is headquartered in Milwaukee, Wisconsin.

Advisors' Opinion:

• [By Laura Brodbeck]

  Tuesday

  Earnings Expected From: Waste Management, Inc. (NYSE: WM), Johnson Controls, Inc. (NYSE: JCI), Electronic Arts Inc. (NASDAQ: EA), LinkedIn Corporation (NYSE: LNKD), Nokia Corporation (NYSE: NOK) Economic Releases Expected: �US consumer confidence, US PPI, Canadian PPI, British mortgage approvals and consumer credit, French consumer confidence

  Wednesday

• [By Dan Caplinger]

  But the big problem for Magna has come from Europe. Rival Johnson Controls (NYSE: JCI  ) , which gets more of its revenue from Europe than from North America, has seen poor conditions in Europe weigh on its overall results. That's consistent with the big problems that major customers Ford (NYSE: F  ) and General Motors (NYSE: GM  ) have seen in their own European sales figures, with Ford having lost $1.75 billion last year in Europe and expecting that figure to balloon upward to $2 billion for 2013. Although GM managed to reduce its European losses in the first quarter to just $175 million, both it and Ford have a lot of work to do in order to get their operations on the continent back to profitability.

Top 10 Promising Stocks To Watch For 2014: Amyris Inc.(AMRS)

Amyris, Inc., an integrated renewable products company, provides alternatives to a range of petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The company uses its industrial synthetic biology platform to modify microorganisms, primarily yeast, to convert plant-sourced sugars into a variety of hydrocarbon molecules that serve as flexible building blocks to be used in a range of products. It is also involved in the sale of ethanol and ethanol blended gasoline to wholesale customers through a network of terminals primarily in the southeastern Unites States. In addition, the company sells farnesene or Biofene, which is used as an ingredient in a range of consumer and industrial products, including detergents, cosmetics, perfumes, and industrial lubricants. Further, it focuses on the commercialization of renewable diesel and jet fuel. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc . in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Among the sector stocks, Amyris (NASDAQ: AMRS) was down more than 4.5 percent, while Southern Copper (NYSE: SCCO)tumbled around 6.3 percent.

  Top Headline
  Big Lots (NYSE: BIG) reported better-than-expected fourth-quarter earnings. For the new fiscal year, Big Lots expects earnings from continuing operations of $2.25 to $2.45 per share, versus analysts' estimates of $2.44 per share. Big Lots posted its quarterly profit of $84.4 million, or $1.45 per share, versus a year-ago profit of $120.3 million, or $2.09 per share. Analysts were expecting earnings of $1.40 per share. Its revenue slipped 6.2% to $1.64 billion, versus analysts' expectations for $1.61 billion. Big Lots' gross margin declined to 38.2% from 39.7%.

• [By Roberto Pedone]

  Amyris (AMRS), a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. This stock closed up 3.3% to $4.02 in Thursday's trading session.

  Thursday's Range: $3.86-$4.04
  
  52-Week Range: $2.17-$6.11
  
  Thursday's Volume: 357,000
  
  Three-Month Average Volume: 202,839

  From a technical perspective, AMRS spiked higher here and broke out above some near-term overhead resistance at $3.97 with above-average volume. This stock has been uptrending for the last three months and change, with shares moving higher from its low of $2.75 to its recent high of $4.19. During that move, shares of AMRS have been making mostly higher lows and higher highs, which is bullish technical price action. This spike higher on Thursday is now starting to push shares of AMRS within range of triggering a big breakout trade. That trade will hit if AMRS manages to take out Thursday's intraday high of $4.04 and then once it clears more near-term overhead resistance at $4.19 with high volume.

  Traders should now look for long-biased trades in AMRS as long as it's trending above its 50-day at $3.73 or its 200-day at $3.64 and then once it sustains a move or close above those breakout levels with volume that hits near or above 202,839 shares. If that gets underway soon, then AMRS will set up to re-test or possibly take out its next major overhead resistance levels at $4.88 to $5.25, or even $5.50.

• [By Jake L'Ecuyer]

  In trading on Wednesday, basic materials shares dropped by 0.30 percent. Among the sector stocks,Amyris (NASDAQ: AMRS) was down more than 8.5 percent, while Universal Stainless & Alloy Products (NASDAQ: USAP) tumbled around 5 percent.

• [By Maxx Chatsko]

  Renewable oils manufacturer Solazyme (NASDAQ: SZYM  ) got walloped after announcing a new commercialization strategy that will result in drastically reduced production volumes from facilities in Clinton, Iowa and Moema, Brazil and less revenue in 2015 and beyond than originally expected. The company's former commercialization strategy of selling massive volumes of commodity replacements relied on optimized, low-cost production and numerous customers. That stood in contrast to the strategy settled into by fellow industrial biotech Amyris (NASDAQ: AMRS  ) at the end of 2012, which relied on producing low volumes of high value products, seeding important long-term markets, driving costs down with new microbial production strains, and adopting an efficient corporate cost structure.

Top 10 Promising Stocks To Watch For 2014: The Advisory Board Company(ABCO)

The Advisory Board Company, together with its subsidiaries, engages in the provision of best practices research and analysis, business intelligence and software tools, and management and advisory services primarily in the United States. The company offers various programs and services, including best practices research services that focus on identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends in the health care and education industries; business intelligence and software tools, which allow members to pair their own operational data with the best practices insights; and management and advisory services programs for assisting member institutions to adopt and implement best practices to enhance performance. As of June 30, 2011, it provided 51 distinct membership programs to hospitals, health systems, colleges, universities, pharmaceutical and biotech companies, health care insurers, medical de vice and supply companies, and other educational institutions. The company was founded in 1979 and is headquartered in Washington, District of Columbia.

Advisors' Opinion:

• [By Jeremy Bowman]

  What: Shares of The Advisory Board Company (NASDAQ: ABCO  ) were up as much as 12% today, after the consulting firm beat top and bottom-line estimates in its quarterly report.

• [By Seth Jayson]

  Advisory Board (Nasdaq: ABCO  ) is expected to report Q4 earnings on May 9. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Advisory Board's revenues will grow 17.4% and EPS will grow 21.7%.

Top 10 Promising Stocks To Watch For 2014: Intellicell Biosciences Inc (SVFC)

Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.

The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.

Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on ! its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.

The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.

The Company competes with Cytori Therapeutics, Stem Cell Assurance, Inc., Osiris, Aastrom Biosciences, Aldagen, BioTime, Baxter International, Celgene, Geron, Harvest Technologies, Mesoblast, Regenexx, NeoStem, X-Cell Center, Stem Cells, Athersys, and Tissue Genesis, Life Technologies, Asterand, pacific biosciences of california inc. and AllCells, LLC.

Advisors' Opinion:

• [By Bryan Murphy]

  Well, though I give myself a C for timing, it looks like I'm going to be able to give myself an A for stock-picking. Back on January 27th I deemed IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) was a compelling buy, and though SVFC was stagnant for a month after that, it looks like the stock's finally getting on its horse. If you didn't get it then, you may want to get in now.

• [By Bryan Murphy]

  To say that shares of IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) has been disappointing since 2011 would be an understatement. SVFC has been an outright disaster since 2011, falling from a peak of $19.00 to a low of, well, just a few pennies as of late last year. In fact, there are those who are understandably wondering how the company is still alive, only producing about a half a million dollars in revenue in 2012, and then dialing that figure back down to nothing for the last few quarters. Yet, there's just something about a company that refuses to go away.... something compelling now.

Top 10 Promising Stocks To Watch For 2014: Ameresco Inc (AMRC)

Ameresco, Inc. incorporated in April 2000, is a provider of energy efficiency solutions for facilities throughout North America. The Company�� services include upgrades to a facility's energy infrastructure and the construction and operation of small-scale renewable energy plants. Its principal service is the development, design, engineering and installation of projects that reduce the energy and operations and maintenance (O&M) costs of its customers' facilities. These projects include a variety of measures customized for the facility and designed to improve the efficiency of major building systems, such as heating, ventilation, air conditioning and lighting systems. It also serves certain customers by developing and building small-scale renewable energy plants located at or close to a customer's site. Ameresco, Inc. provides its services primarily to governmental, educational, utility, healthcare and other institutional, commercial and industrial entities. The Company operates in four segments: U.S. federal, central U.S. region, other U.S. regions and Canada. In August 2011, the Company acquired APS Energy Services Company, Inc. from Pinnacle West Capital Corporation. In December 2011, it acquired the xChange Point and energy projects businesses, including automated demand response, of Energy and Power Solutions, Inc. In August 2012, the Company acquired FAME Facility Software Solutions Inc. In February 2013, it purchased all of the assets of Ennovate Corporation. In June 2013, Ameresco Inc acquired ESP, an energy management consulting company consisting of the Energy Services Partnership and ESP Response, located in Castleford, United Kingdom.

Ameresco, Inc. offers a set of services that includes the design and installation of upgrades to a facility�� energy infrastructure, the design and construction of renewable energy plants, the sale of other renewable energy products and the arranging of financing for customer projects. In September 2010, the Company acquired Quantum Engineer! ing and Development, Inc. In July 2011, the Company acquired Applied Energy Group.

Energy Efficiency Services

The Company�� services includes the design, engineering and installation of, and the arranging of financing for, equipment to improve the efficiency, and control the operation, of a building�� heating, ventilation, cooling and lighting systems. In certain projects, it also designs and constructs a central plant or cogeneration system providing power, heat and/or cooling to a building. Its projects generally range in size and scope from a one-month project to design and retrofit a lighting system to a more complex 30-month project to design and install a central plant or cogeneration system.

Renewable Energy Projects and Products

The Company�� services offering includes the development, construction and operation of, and the arrangement of financing for, small-scale renewable energy plants, as well as the sale and integration of solar energy products and systems. It has constructed and is designing and constructing a range of renewable energy plants using landfill gas (LFG), wastewater treatment biogas, solar, wind, biomass, food waste, animal waste and hydro sources of energy. As part of its renewable energy offering, it also distributes and integrates solar energy products manufactured by several vendors. Ameresco, Inc. is a distributor of photovoltaic (PV) panels, solar regulators, solar charge controllers, inverters, solar powered lighting systems, solar powered water pumps, solar panel mounting hardware and other system components. It also integrates its PV products and system components into solar solutions designed specifically for customers. It provides solar energy solutions for both on- grid applications where the solar power is used in a building connected to a utility distribution system, and for off-grid applications where the power is used directly in the device using the electricity, such as traffic signs.

Amere! sco, Inc.! also designs and constructs renewable energy plants based on wind power. In many parts of the country, available wind resources, utility net metering and local incentives can make on-site wind generation a viable solution for meeting a portion of customers' energy needs. As of December 31, 2010, the Company had completed two projects that included a wind turbine. In addition, it has constructed and was constructing, small-scale renewable energy plants based on biomass.

As of December 31, 2010, Ameresco, Inc. had constructed more than 28 renewable energy projects, and owned and operated 22 small-scale renewable energy plants. Of the owned plants, 19 are renewable LFG plants, two are waste water biogas plants and one is a solar PV installation. These 22 small-scale renewable energy plants have the capacity to generate electricity or deliver LFG producing an aggregate of 106 megawatts (MW) or megawatt-equivalents (MWE). As of December 31, 2010, the Company had signed contracts for the construction, operation and ownership of an additional six LFG plants, two biomass power and cogeneration plants and five biomass boiler projects.

The Company competes with Chevron Energy Solutions, Constellation Energy, Honeywell, Johnson Controls, Siemens Building Technologies and TAC Energy Solutions.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, energy efficiency technologist Ameresco (NYSE: AMRC  ) has earned a coveted five-star ranking.

• [By Sara Murphy]

  Ameresco (NYSE: AMRC  ) is one of the few large, independent energy efficiency service providers. The company's principal service is the development, design, engineering and installation of projects that reduce the energy and operations and maintenance costs of its customers' facilities. Ameresco has seen declining revenues recently because of unusually long lag times in getting its projects funded, but this seems a temporary setback.